Evidence map›Paper›PMID 42236844›Full record

SynthesisScientific reports2026

Comparative efficacy of exercise modes on inflammatory cytokines in patients with breast cancer: a systematic review with pairwise and network meta-analyses.

Mousa Khalafi, Mohammad Hossein Sakhaei, Faeghe Ghasemi, Saeid Fatolahi, Kosar Omidian, Michael E Symonds, Hadi Rohani, Sara K Rosenkranz, Katsuhiko Suzuki, Ayda Sadat Zakeri and 4 more

Abstract readSystematic ReviewNetwork Meta-AnalysisComparative Study
In one paragraph

Synthesis in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mousa KhalafiDepartment of Sport Sciences, Faculty of Humanities, University of Kashan, Kashan, Iran.
Mohammad Hossein SakhaeiDepartment of Exercise Physiology, Faculty of Sport Sciences and Health, University of Tehran, Tehran, Iran. hosseinsakhaei@ut.ac.ir.
Faeghe GhasemiDepartment of Exercise Physiology, Faculty of Sport Sciences, University of Guilan, Guilan, Iran.
Saeid FatolahiDepartment of Physical Education and Sport Sciences, Faculty of Humanities, Tarbiat Modares University, Tehran, Iran.
Kosar OmidianCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.
Michael E SymondsCentre for Perinatal Research, Academic Unit of Population and Lifespan Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
Hadi RohaniDepartment of Exercise Physiology, Sport Sciences Research Institute, Tehran, Iran.
Sara K RosenkranzDepartment of Kinesiology and Nutrition Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
Katsuhiko SuzukiFaculty of Sport Sciences, Waseda University, Tokorozawa, Saitama, Japan.
Ayda Sadat ZakeriDepartment of Sport Sciences, Faculty of Humanities, University of Kashan, Kashan, Iran.
Marziyeh MohammadiyanDepartment of Sport Sciences, Faculty of Humanities, University of Kashan, Kashan, Iran.
Shima MojtahediDepartment of Exercise Physiology, Faculty of Sport Sciences and Health, University of Tehran, Tehran, Iran.
Aref Habibi MalekiPhysiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hossein RafieiDepartment of Nutrition and Dietetics, Saint Louis University, Saint Louis, MO, USA. hossein.rafiei@health.slu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytokines play a key role in the pathogenesis and progression of breast cancer and are increasingly recognized as potential therapeutic targets. The anti-inflammatory effects of regular exercise training are well-established, but its effects on inflammatory adipocytokines in individuals with breast cancer have not been elucidated. This systematic review and pairwise network meta-analyses aimed to (1) investigate the overall effects of exercise training on pro- and anti-inflammatory markers, and (2) compare the efficacy of different exercise modes using pairwise and network meta-analytic approaches. PubMed, Web of Science, and Scopus were systematically searched from inception to January 2025 using four groups of keywords, including "exercise", "cytokine", "breast cancer" and "randomized". Randomized controlled trials investigating the effects of exercise training compared with a control (CON) or other modes of exercise on circulating IL-6, TNF-α, IL-10, CRP, leptin, and adiponectin in patients with breast cancer were included. Standardized mean differences (SMD) with 95% confidence intervals (CIs) were calculated using random-effects models for both pairwise and network meta-analyses. Twenty-four studies involving 1,192 patients with breast cancer were. Compared with CON, exercise training led to significantly larger reductions in IL-6 [SMD: - 0.38, p = 0.03] and leptin [SMD: - 0.77, p = 0.01], and non-significant trends toward reductions in TNF-α [SMD: - 0.29, p = 0.07] and CRP [SMD: - 0.47, p = 0.07], but did not affect IL-10 or adiponectin. In addition, high-intensity interval training (HIIT) reduced IL-6 [SMD: - 1.06, p = 0.02], with non-significant trends toward reduced TNF-α [SMD: - 0.62, p = 0.11] and increased IL-10 [SMD: 0.34, p = 0.09]. Combined training (CT) decreased TNF-α [SMD: - 0.64, p = 0.008], and showed a trend towards lower leptin [SMD: - 0.62, p = 0.06]. No individual exercise mode impacted CRP or adiponectin compared with CON. Exercise training appears to be effective in attenuating some markers of chronic low-grade inflammation by modulating key pro- and anti-inflammatory cytokines in patients with breast cancer, with HIIT and CT may confer superior benefits.

Indexed as

Breast NeoplasmsCytokinesExerciseExercise TherapyAdiponectinFemaleHumansInflammationInflammation MediatorsInterleukin-10Interleukin-6LeptinTumor Necrosis Factor-alphaAdiponectinCytokinesInflammation MediatorsInterleukin-10Interleukin-6LeptinTumor Necrosis Factor-alpha

Identifiers

PMID42236844
PMCPMC13470336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.